Understanding Non-Insulin Injectable Therapies for Diabetes
In recent years, the Food and Drug Administration (FDA) has approved two classes of diabetes medication that are injectable, but not insulin:
- Glucagon-like peptide 1 (GLP-1) receptor agonists
- Amylin analogs
GLP-1 Receptor Agonists
After we eat, our small intestine releases GLP-1, a type of naturally-occurring hormone called an incretin that tells our bodies we’re full. GLP-1 works by slowing the rate at which our stomach empties after eating and by helping the pancreas secrete more insulin; insulin then works with other appetite-regulating hormones to make us feel full. This process lowers blood sugar, suppresses appetite, and causes weight loss.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.